| ²é¿´: 1366 | »Ø¸´: 2 | ||||
organiccooker½ð³æ (ÕýʽдÊÖ)
|
[½»Á÷]
¿ìÀ´¿´FDA¶Ô»¯Ò©·ÖÀà´úÂëµÄÒâÒå£¬ÌØ±ðÊÇOrphan drug ÊÇʲôÒâÒ壬ǧÍò±ðÍûÎÄÉúÒåŶ£¡ ÒÑÓÐ2È˲ÎÓë
|
|
What do the Chemical Type and Review Classification codes stand for? NDA Chemical Types Number Meaning 1 New molecular entity (NME) 2 New active ingredient 3 New dosage form 4 New combination 5 New formulation or new manufacturer 6 New indication 7 Drug already marketed without an approved NDA 8 OTC (over-the-counter) switch 10 New indication submitted as distinct NDA - not consolidated Review Classifications Letter Meaning P Priority review drug: A drug that appears to represent an advance over available therapy S Standard review drug: A drug that appears to have therapeutic qualities similar to those of an already marketed drug O Orphan drug - a product that treats a rare disease affecting fewer than 200,000 Americans ¸öÈ˸оõÐÅÏ¢Á¿ËäС£¬È´ºÜÓÐÒâÒ壡 ¸øµã¹ÄÀøÅ¶ |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
Ò©Æ·×¢²á |
» ²ÂÄãϲ»¶
CSC¸ÄÅÉ-²©Ê¿Éú½»Á÷·Ãѧ
ÒѾÓÐ19È˻ظ´
ÖÐɽ´óѧ-µÚÆßÒ½Ôº-ÕпÆÑÐÖúÀí1Ãû£¨»ùÒòÉè¼ÆºÍ¿Ë¡¡¢RNAºÏ³É£©
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ257È˻ظ´
ÖÐɽ´óѧ-µÚÆßÒ½Ôº-ÕпÆÑÐÖúÀí1Ãû£¨»ùÒòÉè¼ÆºÍ¿Ë¡¡¢RNAºÏ³É£©
ÒѾÓÐ1È˻ظ´
°ÍÀèÈø¿ËÀ×´óѧÓë¹ú¼ÒÁôѧ»ù½ðίºÏ×÷²©Ê¿Ñо¿ÉúÏîÄ¿-Ö¬ÖÊÄÉÃ×Ò©Îï/ÉúÎï²ÄÁÏ/¶à·ÓµÝËÍ
ÒѾÓÐ10È˻ظ´
2026ÉêÇ뿼ºË²©Ê¿×Ô¼ö-µ°°×ÖÊ×éѧ/AI/Ò©ÎïÉè¼Æ/AIDD/»¯Ñ§ÉúÎïѧ
ÒѾÓÐ1È˻ظ´
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ0È˻ظ´
½õÖÝÒ½¿Æ´óѧҩÓÃÉúÎï²ÄÁÏ£¨×¨Òµ´úÂë1007Z1£©ÕÐÊÕµ÷¼Á¿¼Éú
ÒѾÓÐ1È˻ظ´
ÖйúÒ½Ò©ÐÐÒµ·¢Õ¹ÏÖ×´£º±ê×¼Æ·ÍÆ¶¯Ò©Æ·¼ì²âˮƽÌáÉý
ÒѾÓÐ1È˻ظ´
26É격×Ô¼ö
ÒѾÓÐ9È˻ظ´
lbdtian
ÖÁ×ðľ³æ (ÖøÃûдÊÖ)
- Ó¦Öú: 3 (Ó×¶ùÔ°)
- ½ð±Ò: 14682.6
- Ìû×Ó: 2092
- ÔÚÏß: 465.7Сʱ
- ³æºÅ: 1091650
- ×¢²á: 2010-09-07
- ÐÔ±ð: GG
- רҵ: Ò©Îïѧ
2Â¥2013-08-16 10:57:30
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
3Â¥2018-10-26 10:46:54













»Ø¸´´ËÂ¥

